These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 16027862)
21. [Cytoflavin in the complex treatment of neuroinfections in children]. Skripchenko NV; Egorova ES Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(9):28-31. PubMed ID: 22027666 [TBL] [Abstract][Full Text] [Related]
22. [Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.]. Zakharov IK; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Sapozhnikov KV; Zaplutanov VA Adv Gerontol; 2019; 32(3):439-444. PubMed ID: 31512432 [TBL] [Abstract][Full Text] [Related]
23. [Cytoflavin in the detoxification of alcohol-dependent patients]. Minko AI; Linskiĭ IV; Kuz'minov VN; Samoĭlova ES; Goloshchapov VV; Artemchuk KA Zh Nevrol Psikhiatr Im S S Korsakova; 2013; 113(6):35-40. PubMed ID: 23887449 [TBL] [Abstract][Full Text] [Related]
24. [Effect of cytoflavin on the recovery of cognitive function after the cardiaс surgery with artificial blood circulation]. Kardash OF; Shestakova LG; Krachak DI; Chernookiĭ OG; Zasetskiĭ AE; Ostrovskiĭ IuP Zh Nevrol Psikhiatr Im S S Korsakova; 2011; 111(7):76-9. PubMed ID: 21947077 [No Abstract] [Full Text] [Related]
25. [Influence of cytoflavin on symptoms of asthenia, emotional disorders and autonomic regulation in patients with organic asthenic disorder]. Polunina AG; Osinovskaia NA; Gudkova AN; Gekht AB Zh Nevrol Psikhiatr Im S S Korsakova; 2014; 114(2):28-33. PubMed ID: 24662341 [TBL] [Abstract][Full Text] [Related]
26. [An influence of cytoflavin on oxidative stress and activity of Na/K-ATPase of erythrocytes after brain trauma]. Deriugina AV; Shumilova AV Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(11):51-55. PubMed ID: 29265087 [TBL] [Abstract][Full Text] [Related]
27. [Pathogenetic aspects of the use of cytoflavine in the treatment of сhronic post-traumatic headache]. Iskra DA Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(11):41-44. PubMed ID: 28091500 [TBL] [Abstract][Full Text] [Related]
28. [Cardioprotective effect of cytoflavine on a model of doxorubicin-induced cardiomyopathy]. Kashuro VA; Glushkov SI; Novikova TM; Aksenov VV Eksp Klin Farmakol; 2010 Mar; 73(3):15-7. PubMed ID: 20408423 [TBL] [Abstract][Full Text] [Related]
30. [The influence of citoflavin on molecular mechanisms of hypertensive encephalopathy development in patients with systolic arterial hypertension]. Kartashova EA; Romantsov MG; Sarvilina IV Eksp Klin Farmakol; 2014; 77(6):18-23. PubMed ID: 25102730 [TBL] [Abstract][Full Text] [Related]
31. [The use of citoflavin in neonatology and pediatrics as a factor improving therapeutic efficacy in patients with central nervous system lesions of various etiology]. Koval'chuk VV; Zuyeva IB; Nesterin KV; Verulashvili IV; Kortushvili MG Zh Nevrol Psikhiatr Im S S Korsakova; 2018; 118(5. Vyp. 2):46-50. PubMed ID: 30141787 [TBL] [Abstract][Full Text] [Related]
32. [Use of cytoflavin for correction of complications of myocardial infarction]. Bul'on VV; Khnychenko LK; Sapronov NS; Kovalenko AL; Alekseeva LE Eksp Klin Farmakol; 2002; 65(1):27-9. PubMed ID: 12025779 [TBL] [Abstract][Full Text] [Related]
33. [Antioxidant therapy in discirculatory encephalopathy]. Antipenko EA; Gustov AV Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(7):53-5. PubMed ID: 21465819 [No Abstract] [Full Text] [Related]
34. [The preventive treatment of stroke in patients with discirculatory encephalopathy with a depressive syndrome]. Erkebaeva SK; Nurguzhaev ES; Gafurov BG; Tuksanbaeva GU Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(11):32-6. PubMed ID: 23257743 [TBL] [Abstract][Full Text] [Related]
35. [Neuroimmune aspects of the pathogenesis and nitric oxide negative effects modifying the pathogenetic treatment of tick-borne infections]. Kon'kova-Reĭdman AB; Ratnikova LI Zh Nevrol Psikhiatr Im S S Korsakova; 2012; 112(2):40-5. PubMed ID: 22677664 [TBL] [Abstract][Full Text] [Related]
36. [The improvement of treatment efficacy in newborn full-term infants with severe birth asphyxia]. Skoromets AP; Schugareva LM; Shumilina MV; Gorelik YV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(4 Pt 2):83-88. PubMed ID: 27456726 [TBL] [Abstract][Full Text] [Related]
37. [The results of using cytoflavin in conservative treatment of patients with obliterating atherosclerosis of the lower extremity vessels]. Bogomolov MS; Sedov VM; Edovina LN; Luk'ianov IuV; Slobodianiuk VV Vestn Khir Im I I Grek; 2011; 170(1):43-6. PubMed ID: 21506354 [TBL] [Abstract][Full Text] [Related]
38. [Pharmacological correction of free radical disturbances and endotoxicosis in patients with diffuse peritonitis at the postoperative period]. Bagnenko SF; Mirzabaev AT; Batotsyrenov BV; Gorbachev NB; Miroshnichenko VN; Batotsyrenova KhV; Velikiĭ KF Vestn Khir Im I I Grek; 2011; 170(5):14-6, 18. PubMed ID: 22238957 [TBL] [Abstract][Full Text] [Related]
39. [Antioxidant activity of cytoflavin in experimental diffuse purulent peritonitis]. Kosinets VA Eksp Klin Farmakol; 2010 Jan; 73(1):30-2. PubMed ID: 20184286 [TBL] [Abstract][Full Text] [Related]
40. [The use of cytoflavin in reperfusion in ischemic stroke]. Sazonov IE; Lavrenteva IV; Golovina NP Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(3):25-28. PubMed ID: 27070468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]